OmpA is the critical component for Escherichia coli invasion-induced astrocyte activation

Hsueh-Hsia Wu1, Yi-Yuan Yang, Wen-Shyang Hsieh

  • 1Graduate Institute and Department of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Insights

Outer membrane protein A (OmpA) facilitates Escherichia coli invasion of brain cells, contributing to meningitis. Therapeutic use of OmpA may reduce E. coli-induced brain damage and improve survival rates in neonatal meningitis.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Background:

  • Escherichia coli is a primary cause of Gram-negative bacterial neonatal meningitis.
  • Outer membrane protein A (OmpA) is a key E. coli outer membrane protein involved in host-cell interactions.

Purpose of the Study:

  • To investigate the role of OmpA in E. coli invasion of astrocytes.
  • To evaluate the therapeutic potential of OmpA in E. coli meningitis.

Main Methods:

  • Compared OmpA-positive and OmpA-negative E. coli strains for adherence and invasion of C6 glioma cells.
  • Assessed the involvement of actin rearrangement, protein tyrosine kinase, and phosphoinositide 3-kinase in OmpA-mediated invasion.
  • Infected C6 cells and mice intracerebrally with E. coli E44 strain, analyzing astrocyte and inflammatory marker expression.
  • Evaluated the survival rates and brain tissue pathology in mice treated with OmpA.

Main Results:

  • OmpA-positive E. coli strains showed 10- to 15-fold greater adherence and invasion of C6 cells compared to OmpA-negative strains.
  • OmpA-mediated invasion requires actin rearrangement, protein tyrosine kinase, and phosphoinositide 3-kinase activation.
  • E. coli E44 infection induced glial fibrillary acidic protein, cyclooxygenase 2, and nitric oxide synthase 2 expression.
  • Intracerebral E44 infection led to high mortality in mice, while OmpA administration improved survival and reduced brain inflammation.

Conclusions:

  • OmpA-mediated invasion is crucial in the early stages of E. coli-induced brain damage.
  • OmpA demonstrates therapeutic potential for treating E. coli meningitis by mitigating brain injury and enhancing survival.

Related Concept Videos